VALHI, INC. (VHI) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
39/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseVHI / S&P 3.18% / 15.20% |
LoseVHI / S&P 3.38% / 15.00% |
LoseVHI / S&P -152.48% / 50.40% |
| 2026-Q11/3 |
WinVHI / S&P 19.38% / -4.33% |
LoseVHI / S&P -0.68% / 11.30% |
LoseVHI / S&P -162.20% / 27.70% |
| 2025-Q40/3 |
LoseVHI / S&P -23.13% / 2.65% |
LoseVHI / S&P -1.32% / 9.00% |
LoseVHI / S&P -153.70% / 13.40% |
| 2025-Q30/3 |
LoseVHI / S&P -1.86% / 8.12% |
LoseVHI / S&P -0.65% / 4.61% |
LoseVHI / S&P -79.68% / 13.45% |
| 2025-Q21/3 |
LoseVHI / S&P -0.00% / 10.94% |
LoseVHI / S&P 4.04% / 4.83% |
WinVHI / S&P 268.82% / 10.63% |
| 2025-Q12/3 |
LoseVHI / S&P -30.22% / -4.27% |
WinVHI / S&P 7.82% / 4.98% |
WinVHI / S&P 3316.67% / 10.57% |
| 2024-Q41/3 |
LoseVHI / S&P -29.69% / 2.41% |
WinVHI / S&P 9.53% / 5.25% |
LoseVHI / S&P -1281.25% / 6.15% |
| 2024-Q32/3 |
WinVHI / S&P 87.67% / 5.89% |
WinVHI / S&P 10.99% / 5.89% |
LoseVHI / S&P -442.39% / 6.11% |
| 2024-Q21/3 |
LoseVHI / S&P 4.23% / 4.28% |
LoseVHI / S&P 2.73% / 5.38% |
WinVHI / S&P 342.86% / 5.12% |
| 2024-Q11/3 |
WinVHI / S&P 13.76% / 10.56% |
LoseVHI / S&P -6.07% / 5.71% |
LoseVHI / S&P -90.77% / 5.59% |
| 2023-Q41/3 |
WinVHI / S&P 15.22% / 11.69% |
LoseVHI / S&P -13.53% / 6.81% |
LoseVHI / S&P -110.46% / 7.78% |
| 2023-Q31/3 |
WinVHI / S&P 3.82% / -3.27% |
LoseVHI / S&P -25.24% / 7.52% |
LoseVHI / S&P -117.33% / -5.03% |
| 2023-Q20/3 |
LoseVHI / S&P -25.73% / 8.74% |
LoseVHI / S&P -22.45% / 9.50% |
LoseVHI / S&P -96.35% / -8.57% |
| 2023-Q10/3 |
LoseVHI / S&P -20.57% / 7.50% |
LoseVHI / S&P -13.66% / 10.77% |
LoseVHI / S&P -76.45% / -15.69% |
| 2022-Q40/3 |
LoseVHI / S&P -12.25% / 7.56% |
LoseVHI / S&P -3.22% / 11.88% |
LoseVHI / S&P -31.24% / -17.99% |
| 2022-Q31/3 |
LoseVHI / S&P -44.38% / -4.88% |
WinVHI / S&P 17.52% / 13.47% |
LoseVHI / S&P VHI unavailable / -1.41% |
| 2022-Q22/3 |
WinVHI / S&P 54.94% / -16.10% |
WinVHI / S&P 25.68% / 13.71% |
LoseVHI / S&P VHI unavailable / 11.04% |
| 2022-Q12/3 |
WinVHI / S&P 2.27% / -4.60% |
WinVHI / S&P 27.22% / 15.97% |
LoseVHI / S&P VHI unavailable / 42.23% |
| 2021-Q42/3 |
WinVHI / S&P 23.61% / 11.03% |
WinVHI / S&P 24.15% / 15.00% |
LoseVHI / S&P VHI unavailable / 96.40% |
| 2021-Q31/3 |
LoseVHI / S&P -3.79% / 0.58% |
WinVHI / S&P 21.93% / 10.77% |
LoseVHI / S&P VHI unavailable / 69.42% |
| 2021-Q22/3 |
WinVHI / S&P 18.97% / 8.55% |
WinVHI / S&P 13.96% / 6.58% |
LoseVHI / S&P VHI unavailable / 51.81% |
| 2021-Q12/3 |
WinVHI / S&P 35.49% / 6.17% |
WinVHI / S&P 1.19% / -1.06% |
LoseVHI / S&P VHI unavailable / 7.39% |
| 2020-Q42/3 |
WinVHI / S&P 16.07% / 12.15% |
WinVHI / S&P -2.51% / -3.72% |
LoseVHI / S&P VHI unavailable / -33.42% |
| 2020-Q31/3 |
WinVHI / S&P 26.31% / 8.93% |
LoseVHI / S&P -6.69% / -2.04% |
LoseVHI / S&P VHI unavailable / -27.10% |
| 2020-Q20/3 |
LoseVHI / S&P -14.61% / 20.54% |
LoseVHI / S&P -4.78% / -0.46% |
LoseVHI / S&P VHI unavailable / -27.11% |
| 2020-Q10/3 |
LoseVHI / S&P -44.10% / -19.60% |
LoseVHI / S&P 2.37% / 3.47% |
LoseVHI / S&P VHI unavailable / -14.75% |
| 2019-Q40/3 |
LoseVHI / S&P -0.55% / 9.07% |
LoseVHI / S&P 4.25% / 5.36% |
LoseVHI / S&P VHI unavailable / 2.99% |
| 2019-Q30/3 |
LoseVHI / S&P -35.38% / 1.70% |
LoseVHI / S&P -2.86% / 5.02% |
LoseVHI / S&P VHI unavailable / 0.21% |
| 2019-Q21/3 |
WinVHI / S&P 29.87% / 4.30% |
LoseVHI / S&P -5.91% / 6.64% |
LoseVHI / S&P VHI unavailable / 8.65% |
| 2019-Q11/3 |
WinVHI / S&P 20.26% / 13.65% |
LoseVHI / S&P -5.48% / 8.12% |
LoseVHI / S&P VHI unavailable / 14.29% |
| 2018-Q40/3 |
LoseVHI / S&P -14.52% / -13.52% |
LoseVHI / S&P -3.16% / 9.05% |
LoseVHI / S&P VHI unavailable / 18.23% |
| 2018-Q31/3 |
LoseVHI / S&P -51.82% / 7.71% |
WinVHI / S&P 10.50% / 10.21% |
LoseVHI / S&P VHI unavailable / 19.06% |
| 2018-Q21/3 |
LoseVHI / S&P -21.20% / 3.43% |
WinVHI / S&P 18.99% / 9.03% |
LoseVHI / S&P VHI unavailable / 14.46% |
| 2018-Q11/3 |
LoseVHI / S&P -1.48% / -0.76% |
WinVHI / S&P 23.48% / 7.68% |
LoseVHI / S&P VHI unavailable / 12.46% |
| 2017-Q42/3 |
WinVHI / S&P 154.67% / 6.64% |
WinVHI / S&P 23.69% / 7.03% |
LoseVHI / S&P VHI unavailable / 13.82% |
| 2017-Q31/3 |
LoseVHI / S&P -17.70% / 4.48% |
WinVHI / S&P 21.23% / 5.68% |
LoseVHI / S&P VHI unavailable / 17.57% |
| 2017-Q21/3 |
LoseVHI / S&P -8.60% / 3.09% |
WinVHI / S&P 16.91% / 4.83% |
LoseVHI / S&P VHI unavailable / 17.74% |
| 2017-Q11/3 |
LoseVHI / S&P -4.59% / 6.07% |
WinVHI / S&P 10.24% / 3.67% |
LoseVHI / S&P VHI unavailable / 13.32% |
| 2016-Q42/3 |
WinVHI / S&P 51.41% / 3.82% |
WinVHI / S&P 2.12% / 2.09% |
LoseVHI / S&P VHI unavailable / 7.05% |
| 2016-Q31/3 |
WinVHI / S&P 47.65% / 3.85% |
LoseVHI / S&P -12.28% / 0.20% |
LoseVHI / S&P VHI unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | VHI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 11.52% | 20.78% |
| Annualized return | 11.52% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | VHI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -17.46% | 83.14% |
| Annualized return | -3.76% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | VHI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -28.20% | 319.30% |
| Annualized return | -3.26% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LUXFER HOLDINGS PLC (LXFR) | $0.461B | 61.95 | |
| NLI HOLDINGS, INC. (NL) | United States | $0.344B | -11.42 |
| Tronox Holdings plc (TROX) | United States | $0.642B | -1.83 |
| LIGHTBRIDGE Corp (LTBR) | United States | $0.252B | -14.06 |
| LSB INDUSTRIES, INC. (LXU) | United States | $0.727B | 21.14 |
| KRONOS WORLDWIDE INC (KRO) | United States | $0.932B | |
| MINERALS TECHNOLOGIES INC (MTX) | United States | $2.066B | -34.35 |
| Air Products & Chemicals, Inc. (APD) | United States | $63.363B | -1,379.33 |
| LINDE PLC (LIN) | United Kingdom | $215.789B | 33.02 |